| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.025 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |